Loeckie De Zwart - Concepedia

Author

Loeckie De Zwart

Janssen (Belgium)ORCID

Also Known As

L de Zwart, Loeckie De Zwart, Loeckie De Zwart, Loeckie de Zwart, M Hedderson

Publications

Citations

H-Index

Concepts

All Affiliations

Janssen (Belgium)Janssen (United States)Pharmacyclics (United States)AstraZeneca (United Kingdom)Sanofi (United States)

About

Loeckie De Zwart is an author at Janssen (Belgium) specializing in medicine, pharmacology, and pharmacokinetic modeling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	276
2	Education	1	1	22
3	Engineering	1	1	28
4	Health Sciences	1	1	11
5	Anesthesia	1	1	11

Loeckie De Zwart

Publications

640

Citations

H-Index

Page 1

	Year	Citations
Ibrutinib Dosing Strategies Based on Interaction Potential of CYP3A4 Perpetrators Using Physiologically Based Pharmacokinetic Modeling Loeckie De Zwart, Jan Snoeys, Jan de Jong, Clinical Pharmacology & Therapeutics	2016	109
The ontogeny of drug metabolizing enzymes and transporters in the rat Loeckie De Zwart, Martijn Scholten, Johan Monbaliu, Reproductive Toxicology Pharmacological StudyBiochemistryMedicinePhysiologyToxicology	2008	86
Stable isotope‐labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults Ronald de Vries, Johan W. Smit, Peter Hellemans, British Journal of Clinical Pharmacology	2015	70
A drug–drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies Jan de Jong, Peter Hellemans, Severijn De Wilde, Leukemia & lymphoma/Leukemia and lymphoma	2018	47
IMI – oral biopharmaceutics tools project – evaluation of bottom-up PBPK prediction success part 1: Characterisation of the OrBiTo database of compounds Alison Margolskee, Adam S. Darwich, Xavier Pépin, European Journal of Pharmaceutical Sciences Pharmacokinetic ModelingBiochemistryMedicineRational Drug DesignAnalytical Chemistry	2016	42
Blood Microsampling Using Capillaries for Drug-Exposure Determination in Early Preclinical Studies: A Beneficial Strategy to Reduce Blood Sample Volumes Lieve Dillen, Tine Loomans, Guy Van de Perre, Bioanalysis	2014	35
The Application of Capillary Microsampling in Glp Toxicology Studies Tom Verhaeghe, Lieve Dillen, Hans Stieltjes, Bioanalysis	2017	28
Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects Joris Vandenbossche, Wolfgang Jessner, Maarten van den Boer, Advances in Therapy Healthy SubjectsViral HepatitisMedicineImmunologyHepatitis B	2019	28
Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective Niresh Hariparsad, Diane Ramsden, Kunal S. Taskar, Clinical Pharmacology & Therapeutics EngineeringGap AnalysisMolecular BiologyPhysiologically-based Pharmacokinetic ModelingBioanalysis	2021	28
Pharmacokinetic Drug–Drug Interaction of Apalutamide, Part 2: Investigating Interaction Potential Using a Physiologically Based Pharmacokinetic Model An Van den Bergh, Jan Snoeys, Loeckie De Zwart, Clinical Pharmacokinetics Pharmacokinetic ModelingPharmacodynamicsMedicinePart 2Pharmacokinetic Drug–drug Interaction	2020	25

Page 1